Nascent Medical Therapies for Abdominal Aneurysms

Overview

Journal J Am Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2018 Oct 30

PMID 30371312

Citations 1

Authors

Neal R Barshes

Affiliations

Soon will be listed here.

Citing Articles

Nascent Medical Therapies for Abdominal Aneurysms.

Barshes N J Am Heart Assoc. 2018; 7(19):e010458.

PMID: 30371312 PMC: 6404873. DOI: 10.1161/JAHA.118.010458.

References

Preiss D, Lloyd S, Ford I, McMurray J, Holman R, Welsh P . Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes Endocrinol. 2014; 2(2):116-24. DOI: 10.1016/S2213-8587(13)70152-9. View

Gray C, Goodman P, Cullen P, Badger S, OMalley K, ODonohoe M . Screening for Peripheral Arterial Disease and Carotid Artery Disease in Patients With Abdominal Aortic Aneurysm. Angiology. 2015; 67(4):346-9. DOI: 10.1177/0003319715590299. View

Fujimura N, Xiong J, Kettler E, Xuan H, Glover K, Mell M . Metformin treatment status and abdominal aortic aneurysm disease progression. J Vasc Surg. 2016; 64(1):46-54.e8. PMC: 4925242. DOI: 10.1016/j.jvs.2016.02.020. View

Halle T, Benarroch-Gampel J, Teodorescu V, Rajani R . Surgical Intervention for Peripheral Artery Disease Does Not Improve Patient Compliance with Recommended Medical Therapy. Ann Vasc Surg. 2017; 46:104-111. DOI: 10.1016/j.avsg.2017.06.152. View

Gerhard-Herman M, Gornik H, Barrett C, Barshes N, Corriere M, Drachman D . 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016; 135(12):e686-e725. PMC: 5479414. DOI: 10.1161/CIR.0000000000000470. View

Lee C, Lee M, Chen Y, Lee S, Chen Y, Chen S . Risk of Aortic Dissection and Aortic Aneurysm in Patients Taking Oral Fluoroquinolone. JAMA Intern Med. 2015; 175(11):1839-47. DOI: 10.1001/jamainternmed.2015.5389. View

Petrinec D, Liao S, Holmes D, Reilly J, Parks W, Thompson R . Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg. 1996; 23(2):336-46. DOI: 10.1016/s0741-5214(96)70279-3. View

Salata K, Syed M, Hussain M, de Mestral C, Greco E, Mamdani M . Statins Reduce Abdominal Aortic Aneurysm Growth, Rupture, and Perioperative Mortality: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2018; 7(19):e008657. PMC: 6404894. DOI: 10.1161/JAHA.118.008657. View

Barshes N . Nascent Medical Therapies for Abdominal Aneurysms. J Am Heart Assoc. 2018; 7(19):e010458. PMC: 6404873. DOI: 10.1161/JAHA.118.010458. View

10.

LeMaire S, Zhang L, Luo W, Ren P, Azares A, Wang Y . Effect of Ciprofloxacin on Susceptibility to Aortic Dissection and Rupture in Mice. JAMA Surg. 2018; 153(9):e181804. PMC: 6233654. DOI: 10.1001/jamasurg.2018.1804. View

11.

Myers J, McElrath M, Jaffe A, Smith K, Fonda H, Vu A . A randomized trial of exercise training in abdominal aortic aneurysm disease. Med Sci Sports Exerc. 2013; 46(1):2-9. DOI: 10.1249/MSS.0b013e3182a088b8. View

12.

Meltzer A, Sedrakyan A, Connolly P, Ellozy S, Schneider D . Risk Factors for Suboptimal Utilization of Statins and Antiplatelet Therapy in Patients Undergoing Revascularization for Symptomatic Peripheral Arterial Disease. Ann Vasc Surg. 2017; 46:234-240. DOI: 10.1016/j.avsg.2017.05.030. View

13.

Stone N, Robinson J, Lichtenstein A, Merz C, Blum C, Eckel R . 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 129(25 Suppl 2):S1-45. DOI: 10.1161/01.cir.0000437738.63853.7a. View

14.

Golledge J, Norman P . Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors?. Arterioscler Thromb Vasc Biol. 2010; 30(6):1075-7. PMC: 2874982. DOI: 10.1161/ATVBAHA.110.206573. View

15.

De Martino R, Hoel A, Beck A, Eldrup-Jorgensen J, Hallett J, Upchurch G . Participation in the Vascular Quality Initiative is associated with improved perioperative medication use, which is associated with longer patient survival. J Vasc Surg. 2015; 61(4):1010-9. PMC: 5315460. DOI: 10.1016/j.jvs.2014.11.073. View

16.

Lederle F . The rise and fall of abdominal aortic aneurysm. Circulation. 2011; 124(10):1097-9. DOI: 10.1161/CIRCULATIONAHA.111.052365. View

17.

Rughani G, Robertson L, Clarke M . Medical treatment for small abdominal aortic aneurysms. Cochrane Database Syst Rev. 2012; 9):CD009536. PMC: 11707027. DOI: 10.1002/14651858.CD009536.pub2. View

18.

Curci J, Petrinec D, Liao S, Golub L, Thompson R . Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines. J Vasc Surg. 1998; 28(6):1082-93. DOI: 10.1016/s0741-5214(98)70035-7. View

19.

Golledge J, Moxon J, Pinchbeck J, Anderson G, Rowbotham S, Jenkins J . Association between metformin prescription and growth rates of abdominal aortic aneurysms. Br J Surg. 2017; 104(11):1486-1493. DOI: 10.1002/bjs.10587. View

20.

Pinchbeck J, Moxon J, Rowbotham S, Bourke M, Lazzaroni S, Morton S . Randomized Placebo-Controlled Trial Assessing the Effect of 24-Week Fenofibrate Therapy on Circulating Markers of Abdominal Aortic Aneurysm: Outcomes From the FAME -2 Trial. J Am Heart Assoc. 2018; 7(19):e009866. PMC: 6404864. DOI: 10.1161/JAHA.118.009866. View